Skip to content
Trial Eligibility
Menu

Hidradenitis Suppurativa Clinical Trials Recruiting in the US

28 studies for Hidradenitis Suppurativa are recruiting at 249 US sites, according to ClinicalTrials.gov data processed .

Hidradenitis suppurativa is a long-term skin condition that causes painful lumps under the skin, often in the armpits or groin.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Top Hidradenitis Suppurativa studies by number of US sites

Showing 28 studies, most US recruiting sites first.
  1. Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

    NCT06855498

    • Phase 3
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    74 US recruiting sites
  2. Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

    NCT07213973

    • Phase 2
    • Ages 12 to 17 years
    • Sex: All
    Recruiting sites
    24 US recruiting sites
  3. An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

    NCT07665437

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All
    Recruiting sites
    21 US recruiting sites
  4. A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

    NCT07225569

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    20 US recruiting sites
  5. Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

    NCT07170917

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    17 US recruiting sites
  6. Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

    NCT07049575

    • Phase 1
    • Ages 12 to 75 years
    • Sex: All
    Recruiting sites
    16 US recruiting sites
  7. A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

    NCT07384975

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All
    Recruiting sites
    14 US recruiting sites
  8. ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

    NCT07783542

    • Phase 2
    • Ages 18 to 79 years
    • Sex: All
    Recruiting sites
    14 US recruiting sites
  9. Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa

    NCT07828860

    • Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    9 US recruiting sites
  10. A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

    NCT07123038

    • Observational
    • Ages 18 to 71 years
    • Sex: All
    Recruiting sites
    7 US recruiting sites
  11. Myriad™ Augmented Soft Tissue Reconstruction Registry

    NCT05243966

    • Observational
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    6 US recruiting sites
  12. A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

    NCT06888193

    • Phase 1
    • Ages 18 years and older
    • Sex: Female
    Recruiting sites
    6 US recruiting sites
  13. A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

    NCT07244263

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    4 US recruiting sites
  14. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

    NCT06524635

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All
    Recruiting sites
    2 US recruiting sites
  15. Radiotherapy for Refractory Hidradenitis Suppurativa

    NCT07414550

    • Interventional
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    2 US recruiting sites
  16. The Ohio State University Dermatology Biorepository

    NCT03146676

    • Observational
    • Ages Any age
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    1 US recruiting site
  17. Clinical and Biological Characteristics of Hidradenitis Suppurativa

    NCT03967600

    • Observational
    • Ages 13 years and older
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    1 US recruiting site
  18. Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

    NCT04115566

    • Observational
    • Ages 10 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  19. Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

    NCT04218422

    • Interventional
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  20. Targeting Nociceptors in Hidradenitis Suppurativa

    NCT05403710

    • Observational
    • Ages 18 to 75 years
    • Sex: All
    Recruiting sites
    1 US recruiting site
  21. Regulation of Inflammatory Genes in Hidradenitis Suppurativa

    NCT05507125

    • Observational
    • Ages 18 to 89 years
    • Sex: All
    Recruiting sites
    1 US recruiting site
  22. Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

    NCT06058520

    • Early Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  23. Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

    NCT06326476

    • Early Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  24. Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%

    NCT06645821

    • Early Phase 1
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  25. 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

    NCT07155239

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All
    • Accepts healthy volunteers
    Recruiting sites
    1 US recruiting site
  26. The Safety and Efficacy of Roflumilast Foam in HS

    NCT07263230

    • Phase 2
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  27. Pelashield™ PainGuard™ vs Restrata® in HS Surgery

    NCT07316192

    • Interventional
    • Ages 18 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site
  28. Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

    NCT07689188

    • Phase 2
    • Ages 12 years and older
    • Sex: All
    Recruiting sites
    1 US recruiting site

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Hidradenitis Suppurativa clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.